hyposensitization

(redirected from Allergy immunotherapy)
Also found in: Medical.

hyposensitization

[¦hī·pō‚sen·səd·ə′zā·shən]
(communications)
Mentioned in ?
References in periodicals archive ?
The website, launching during May, National Asthma and Allergy Awareness month, will be the first dedicated to the importance of allergy immunotherapy.
Our results suggest that among children with allergic rhinitis, allergy immunotherapy may produce a significant healthcare cost-offset benefit within the first 18 months," said Dr.
Allergy immunotherapy also reduces the incidence of asthma and the development of new environmental allergies.
Now, SkinVet (TM) has introduced prescription solutions that break down both barriers, making allergy immunotherapy available to many more allergic pets.
GRAZAX(R) has been studied in the largest clinical trial program ever conducted within allergy immunotherapy comprising six clinical trials and a total of more than 1,700 patients.
Approximately 30 percent of study participants also had asthma, which in the past has proven to be a challenging population to treat with allergy immunotherapy.
This re-education of the immune system response is the basis of the medically accepted paradigm for treating allergy by conventional allergy immunotherapy.
The GT-07 study demonstrates the efficacy and confirms the favourable safety profile of the grass tablet, recently reported in the phase IIb/III trial (GT-02) - the largest allergy immunotherapy study ever performed[1].
Furthermore, we worked diligently in 2011 to move our allergy immunotherapy manufacturing to our Des Moines facility and the addition of this product opportunity enhances those economic benefits.
Greer, a leading developer and provider of allergy immunotherapy products, today announced the results of its Phase IIb double-blind placebo-controlled dose response trial for the sublingual-oral immunotherapy (SLIT) administration of its standardized short ragweed pollen extract.
Larry Garner, HollisterStier Allergy's National Allergy Consultant and well-known lecturer on allergy immunotherapy and dosing, will be hosting the webinars.
TOLAMBA(TM), a ragweed allergy immunotherapy in Phase 2; a therapy for metastatic colorectal cancer in Phase 1; and a therapy for hepatitis B in Phase 1.

Full browser ?